KY HB469 | 2025 | Regular Session

Status

Spectrum: Partisan Bill (Republican 10-0)
Status: Introduced on February 12 2025 - 25% progression
Action: 2025-02-14 - to Health Services (H)
Pending: House Health Services Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Create a new section of KRS Chapter 214 to establish legislative intent; define terms; establish that a person in the Commonwealth shall not administer, by any route or modality, any human gene therapy product for any infectious disease indication, regardless of whether the administration is termed an immunization, vaccine, or any other term; exempt human gene therapy products used to treat cancer or genetic disorders; sunset the provisions on July 1, 2035, unless extended by the General Assembly; EMERGENCY.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

AN ACT relating to human gene therapy products and declaring an emergency.

Sponsors


History

DateChamberAction
2025-02-14Houseto Health Services (H)
2025-02-12Houseto Committee on Committees (H)
2025-02-12Houseintroduced in House

Subjects


Kentucky State Sources


Bill Comments

feedback